Chapter 33: Biologic Therapies
Loading audio…
ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.
Biologic therapies represent a distinct category of psychiatric treatment that operates through direct manipulation of brain physiology and neural circuitry, complementing pharmacological and psychotherapeutic strategies. Electroconvulsive therapy remains the gold standard for severe catatonia, acute mania, and treatment-resistant depression, operating through mechanisms involving seizure-induced neurochemical changes, enhanced synaptic plasticity, and reorganization of functional brain networks. The chapter details how ECT modulates neurotransmitter systems and restores disrupted connectivity patterns, making it particularly valuable when rapid response is clinically essential. Transcranial magnetic stimulation applies magnetic fields to alter cortical excitability and has established efficacy in major depressive disorder without requiring anesthesia or inducing seizures. Vagus nerve stimulation and deep brain stimulation represent more invasive neuromodulation strategies targeting specific neural circuits implicated in depression, obsessive-compulsive disorder, and other refractory conditions. Light therapy addresses seasonal affective disorder and circadian dysregulation through entrainment of biological rhythms and effects on serotonergic and circadian neural systems. Biofeedback and neurofeedback techniques enable patients to voluntarily modulate autonomic and cortical activity through real-time physiological monitoring. The chapter emphasizes critical assessment factors including patient selection criteria, safety profiles, potential adverse effects, and ethical implications of each modality. Contemporary practice increasingly recognizes that biologic therapies function most effectively within integrated treatment frameworks combining pharmacotherapy and psychotherapy. The discussion incorporates mechanistic understanding grounded in contemporary neuroscience while maintaining clinical pragmatism regarding treatment outcomes, patient preferences, and resource allocation in psychiatric care.